Annual EBIT
-$29.99 M
+$12.72 M+29.78%
December 31, 2022
Summary
- As of February 7, 2025, ARDS annual earnings before interest & taxes is -$29.99 million, with the most recent change of +$12.72 million (+29.78%) on December 31, 2022.
- During the last 3 years, ARDS annual EBIT has fallen by -$906.00 thousand (-3.11%).
- ARDS annual EBIT is now -280.43% below its all-time high of -$7.88 million, reached on December 31, 2016.
Performance
ARDS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$869.00 K
-$14.54 M-106.36%
September 30, 2023
Summary
- As of February 7, 2025, ARDS quarterly earnings before interest & taxes is -$869.00 thousand, with the most recent change of -$14.54 million (-106.36%) on September 30, 2023.
- Over the past year, ARDS quarterly EBIT has dropped by -$14.54 million (-106.36%).
- ARDS quarterly EBIT is now -106.36% below its all-time high of $13.67 million, reached on June 30, 2023.
Performance
ARDS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$883.00 K
+$6.54 M+88.11%
September 30, 2023
Summary
- As of February 7, 2025, ARDS TTM earnings before interest & taxes is -$883.00 thousand, with the most recent change of +$6.54 million (+88.11%) on September 30, 2023.
- Over the past year, ARDS TTM EBIT has increased by +$6.54 million (+88.11%).
- ARDS TTM EBIT is now at all-time high.
Performance
ARDS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ARDS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.8% | -106.4% | +88.1% |
| 3 y3 years | -3.1% | +85.0% | +96.0% |
| 5 y5 years | -52.0% | +88.3% | +97.0% |
ARDS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.8% | -106.4% | +89.8% | at high | +98.0% |
| 5 y | 5-year | -33.9% | +29.8% | -106.4% | +95.9% | at high | +98.0% |
| alltime | all time | -280.4% | +29.8% | -106.4% | +95.9% | at high | +98.0% |
Aridis Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$869.00 K(-106.4%) | -$883.00 K(-88.1%) |
| Jun 2023 | - | $13.67 M(-318.3%) | -$7.43 M(-74.2%) |
| Mar 2023 | - | -$6.26 M(-15.6%) | -$28.83 M(-3.9%) |
| Dec 2022 | -$29.99 M(-29.8%) | -$7.42 M(+0.1%) | -$29.99 M(-3.6%) |
| Sep 2022 | - | -$7.41 M(-4.2%) | -$31.13 M(-30.4%) |
| Jun 2022 | - | -$7.74 M(+4.2%) | -$44.74 M(+3.5%) |
| Mar 2022 | - | -$7.42 M(-13.2%) | -$43.24 M(+1.2%) |
| Dec 2021 | -$42.71 M(+90.7%) | -$8.55 M(-59.3%) | -$42.71 M(+6.8%) |
| Sep 2021 | - | -$21.03 M(+237.3%) | -$39.98 M(+61.6%) |
| Jun 2021 | - | -$6.23 M(-9.6%) | -$24.75 M(+8.8%) |
| Mar 2021 | - | -$6.90 M(+18.5%) | -$22.74 M(+1.5%) |
| Dec 2020 | -$22.40 M | -$5.82 M(+0.5%) | -$22.40 M(+0.6%) |
| Sep 2020 | - | -$5.79 M(+36.9%) | -$22.27 M(-6.7%) |
| Jun 2020 | - | -$4.23 M(-35.5%) | -$23.87 M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$6.56 M(+15.2%) | -$27.91 M(-4.1%) |
| Dec 2019 | -$29.09 M(+20.6%) | -$5.69 M(-23.1%) | -$29.09 M(+0.4%) |
| Sep 2019 | - | -$7.39 M(-10.5%) | -$28.98 M(+2.7%) |
| Jun 2019 | - | -$8.27 M(+6.8%) | -$28.20 M(+15.2%) |
| Mar 2019 | - | -$7.74 M(+38.7%) | -$24.48 M(+1.5%) |
| Dec 2018 | -$24.12 M(+22.2%) | -$5.58 M(-15.8%) | -$24.12 M(+4.9%) |
| Sep 2018 | - | -$6.62 M(+45.5%) | -$22.99 M(+5.2%) |
| Jun 2018 | - | -$4.55 M(-38.3%) | -$21.86 M(+2.7%) |
| Mar 2018 | - | -$7.37 M(+65.5%) | -$21.29 M(+7.8%) |
| Dec 2017 | -$19.74 M(+150.4%) | -$4.45 M(-18.8%) | -$19.74 M(+29.1%) |
| Sep 2017 | - | -$5.49 M(+37.9%) | -$15.29 M(+56.0%) |
| Jun 2017 | - | -$3.98 M(-31.7%) | -$9.80 M(+68.3%) |
| Mar 2017 | - | -$5.82 M | -$5.82 M |
| Dec 2016 | -$7.88 M | - | - |
FAQ
- What is Aridis Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual EBIT year-on-year change?
- What is Aridis Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly EBIT year-on-year change?
- What is Aridis Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals TTM EBIT year-on-year change?
What is Aridis Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ARDS is -$29.99 M
What is the all time high annual EBIT for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.88 M
What is Aridis Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ARDS annual earnings before interest & taxes has changed by +$12.72 M (+29.78%)
What is Aridis Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ARDS is -$869.00 K
What is the all time high quarterly EBIT for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly earnings before interest & taxes is $13.67 M
What is Aridis Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ARDS quarterly earnings before interest & taxes has changed by -$14.54 M (-106.36%)
What is Aridis Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ARDS is -$883.00 K
What is the all time high TTM EBIT for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high TTM earnings before interest & taxes is -$883.00 K
What is Aridis Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ARDS TTM earnings before interest & taxes has changed by +$6.54 M (+88.11%)